Scholars Central

Conference abstractPublished 12 Jun 2023

Risk reducing mastectomy, when should we do it?

Authors: Rabbia Khan

American College of Surgeons, UAE

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND Recent progress in understanding the genetic basis of breast cancer and widely publicized reports of celebrities undergoing risk-reducing mastectomy (RRM) have increased interest in RRM as a method of preventing breast cancer. A generalized concern has been raised regarding the trend toward an over-aggressive surgical approach to breast cancer because even if RRM is nowadays a routine operation, it still remains a major intervention, with potentially protracted recovery, risk for serious complications, and long-term sequelae. It is therefore very important for physicians to be aware of this tendency, its drivers, and the evidence-based data. METHODS We looked at our data from Mediclinic cancer comprehensive center and determined the rate of risk reducing mastectomy, prophylactic mastectomy (ipsilateral and contralateral) and their relation with genetic mutation or family history. We excluded the survival benefit and rate of recurrence as we still need to observe these patients for at least 5 years to determine that. OBSERVATION Majority of the decisions were made out of fear for not having the cancer back. Aesthetics reasons were rare. However fewer patients opted due to genetic mutation as well.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Rabbia Khan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels